Public Company News
AUTOCRYPT Announces Successful KOSDAQ Listing
SEOUL, South Korea, July 16, 2025 /PRNewswire/ -- AUTOCRYPT, a leading global provider of automotive software and cybersecurity solutions, announced its official listing on the KOSDAQ market of the Korean Exchange (KRX) onJuly 15th, 2025. The listing is expected to enhance AUTOCRYPT's global visi...
2025-07-16 20:00
2832
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics
* Best ESG rating tier of negligible-risk with a top 1% global ranking score * Industry and Regional ESG Top-Rated Company for five consecutive years * Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, July 16, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading ...
2025-07-16 18:00
2420
Yum China to Report Second Quarter 2025 Financial Results
SHANGHAI, July 16, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2025 before the U.S. market opens on Tuesday, August 5, 2025 (after t...
2025-07-16 17:00
3690
LG BRINGS PREMIUM STREAMING TO NEW KIA MODELS IN EUROPE WITH WEBOS AUTOMOTIVE CONTENT PLATFORM
Proven In-Car Entertainment Solution Delivers Immersive Media Experiences and Transforms New Kia Models into "Living Spaces on Wheels" SEOUL, South Korea, July 16, 2025 /PRNewswire/ -- LG Electronics (LG), a leading innovator in mobility technology, announced that its webOS-based Automotive Cont...
2025-07-16 14:00
2549
Zeekr Group to Report Second Quarter 2025 Financial Results on August 14, 2025
HANGZHOU, China, July 16, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2...
2025-07-16 13:00
3552
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors
TAIPEI and SAN DIEGO, July 15, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug Pidnarulex (CX-5461) has been selected by the U...
2025-07-16 10:32
2889
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer
HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phase III clinical trial (AK112-312/HARMONi-GI6) of ivonescimab in first-line treatment for advanced metastati...
2025-07-16 09:47
2774
Fly-E Group, Inc. Announces Fiscal Year 2025 Financial Results
NEW YORK, July 15, 2025 /PRNewswire/ -- Fly-E Group, Inc. (Nasdaq: FLYE) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced its financialresults for the f...
2025-07-16 08:00
3472
Scienjoy Holding Corporation Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
BEIJING, July 15, 2025 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced that the Company had received a notification letter (the "Notification Letter") datedJuly 10, 2025 from...
2025-07-16 04:30
4859
Paranovus Entertainment Technology Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq
NEW YORK, July 15, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"),(NASDAQ: PAVS) announced today that on July 11, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq"), not...
2025-07-16 04:15
4582
LG Unveils Korea's First Open-weight Hybrid AI, 'EXAONE 4.0'
Proving Superior Performance in Benchmarks Against Leading Open-Weight Models from the US,China, and France. SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- On July 15, the LG AI Research unveiled EXAONE 4.0, the first open-weight hybrid AI model in Korea. EXAONE 4.0 is a groundbreaking model ...
2025-07-15 22:00
4613
FIC Global Leads the Switch from Electrons to Photons for AI Factories
With 16 years of expertise in optical communications, FIC Global is powering the next wave of advancement for AI with leading-edge optical transceivers up to 1.6T and beyond. TAIPEI, July 15, 2025 /PRNewswire/ -- As artificial intelligence continues to reshape the global economy, fiber optic con...
2025-07-15 20:09
2014
Jianzhi Education Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
BEIJING, July 15, 2025 /PRNewswire/ -- Jianzhi Education Technology Group Company Limited (the "Company" or "Jianzhi") (NASDAQ: JZ), a leading provider of digital educational content inChina, today announced that the Company has received written a notification from the staff of the Listing Qualif...
2025-07-15 20:00
3520
Baidu and Uber Join Forces to Accelerate Autonomous Vehicle Deployment
BEIJING and SAN FRANCISCO, July 15, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888) and Uber Technologies, Inc. (NYSE: UBER) today announced a multi-year strategic partnership to deploy thousands of Baidu's Apollo Go autonomous vehicles (AVs) on the Uber platform across multiple gl...
2025-07-15 20:00
1979
GIBO Click Successfully Completes Monetization Engine Trial on DramaFlow, Expanding Smart Infrastructure in Short-Drama Platforms
HONG KONG, July 15, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a
leader in smart content monetization technology, today announced the successful
testing ofGIBO Click's multi-currency settlement and analytics engine on the
fast-growing short-drama platformDramaFlow
2025-07-15 19:30
3277
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Nietham...
2025-07-15 19:30
2195
Tencent Music Entertainment Group to Report Second Quarter 2025 Financial Results on August 12, 2025
SHENZHEN, China, July 15, 2025 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the second quarter of ...
2025-07-15 18:00
3465
Zeekr Group Enters into Definitive Merger Agreement for Acquisition Transaction
HANGZHOU, China, July 15, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it has entered into an Agreement and Plan of Merger (the "Merger Agreement") with Gee...
2025-07-15 18:00
3196
Full Truck Alliance Co. Ltd. Releases 2024 Environmental, Social and Governance Report
GUIYANG, China, July 15, 2025 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced the release of its 2024 Environmental, Social and Governance ("ESG") report. The report highlights FTA's ongoing efforts to integrat...
2025-07-15 17:00
3685
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
- The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day 29 of a single-dose of ultra-long-acting subcutaneously administered ASC47 (half-life up to 40 days) in combination with four doses of semaglutide (0.5 mg, onc...
2025-07-15 07:00
2495
Week's Top Stories
Most Reposted
DBS crowned Southeast Asia's most valuable brand in Kantar BrandZ 2026 ranking
[Picked up by 305 media titles]
2026-07-15 12:00
Visa Reimagines Visa Infinite for Asia Pacific's Modern Affluent
[Picked up by 301 media titles]
2026-07-16 10:00
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 295 media titles]
2026-07-10 13:30
Gnomey Hollows Opens at PARKROYAL COLLECTION Marina Bay, Singapore, Extending the Hotel's Gnome-Themed Family Experience
[Picked up by 289 media titles]
2026-07-13 11:42
Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry
[Picked up by 287 media titles]
2026-07-13 10:00
Most Read
NYSE Content Update: Samos Energy Acquisition to Make NYSE Debut
2026-07-10 21:04
10114
Elong Power Holding Limited Announces Pricing of US$6.6 Million Public Offering
2026-07-10 20:30
9657
Waton Financial Launches MoTA Alpha, Marking Full Strategic Pivot to AI-Native Finance
2026-07-10 10:32
7959